학술논문
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial
Document Type
Article
Author
Source
In The Lancet Infectious Diseases February 2024 24(2):150-160
Subject
Language
ISSN
1473-3099